Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tivic Health Systems Inc (TIVC)

Tivic Health Systems Inc (TIVC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,384
  • Shares Outstanding, K 1,766
  • Annual Sales, $ 780 K
  • Annual Income, $ -5,660 K
  • EBIT $ -7 M
  • EBITDA $ -7 M
  • 60-Month Beta 1.98
  • Price/Sales 2.27
  • Price/Cash Flow N/A
  • Price/Book 0.42

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.2606 +7.09%
on 01/08/26
2.7000 -50.00%
on 12/11/25
-0.9800 (-42.06%)
since 12/09/25
3-Month
1.2606 +7.09%
on 01/08/26
3.0600 -55.88%
on 10/14/25
-1.6100 (-54.39%)
since 10/09/25
52-Week
1.2606 +7.09%
on 01/08/26
15.6400 -91.37%
on 02/13/25
-3.5970 (-72.71%)
since 01/08/25

Most Recent Stories

More News
Tivic Expands Intellectual Property Portfolio

New Biologics Patent Application Covers Potential Applicability of TLR5 Agonists to Improve Outcomes for Late-stage Cancer Therapies; Bioelectronic Patent Covers Optimized ncVNS Device Specifications

TIVC : 1.3500 (-4.93%)
Tivic Health to Report Third Quarter 2025 Financial Results on November 14th Via Conference Call and Webcast

Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that it will report its third quarter results for 2025 via pre-recorded conference call and...

TIVC : 1.3500 (-4.93%)
Tivic CEO, Jennifer Ernst, to Join Panel at 8th Annual Northwell Health Innovation Constellation Forum on Thursday, Oct. 23

Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that CEO, Jennifer Ernst, will participate in the eighth annual Constellation Forum, a global...

TIVC : 1.3500 (-4.93%)
Tivic Health Systems Announces New CEO Employment Agreement

Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Tivic Health...

TIVC : 1.3500 (-4.93%)
Tivic Health CEO Jennifer Ernst to Present at Emerging Growth’s September Virtual Conference

Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company, today announced that the company’s CEO will present during the Emerging Growth virtual conference set to...

TIVC : 1.3500 (-4.93%)
Tivic Completes Verification of Entolimodâ„¢ Cell Line: First Step in Establishing CGMP Manufacturing for BLA Filing

 

TIVC : 1.3500 (-4.93%)
Tivic Receives Two Investigational New Drug Applications for Entolimodâ„¢ for the Treatment of Acute Radiation Syndrome (ARS) and Advanced Cancers

INDs Transferred from Statera Biopharma Advance Entolimod for ARS Along Regulatory Pathway and Enable Pursuit of Clinical Trial Program in Neutropenia and Lymphocyte Exhaustion ...

TIVC : 1.3500 (-4.93%)
Tivic Health Advances Discussions on Use of Entolimod as a Radiation Countermeasure at Military Health System Research Symposium 2025

Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, is proud to announce it advanced discussions with key US Government agencies through its participation in the 2025 Military...

TIVC : 1.3500 (-4.93%)
Tivic Reports Second Quarter 2025 Financial Results

Company advances its TLR5 agonist program and prepares to report VNS clinical data

TIVC : 1.3500 (-4.93%)
Tivic Health to Report Second Quarter 2025 Financial Results on August 14th Via Conference Call and Webcast

Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified immunotherapeutics company developing treatments that stimulate immune pathways to treat disease, today announced that it will report its second...

TIVC : 1.3500 (-4.93%)

Business Summary

Tivic Health Systems Inc. is a commercial-phase healthtech company advancing bioelectronic medicine to deliver non-invasive solutions which treat disease, increase wellness and improve lives. Its first product includes ClearUP(R). Tivic Health Systems Inc. is based in MENLO PARK, Calif.

See More

Key Turning Points

3rd Resistance Point 1.5967
2nd Resistance Point 1.5433
1st Resistance Point 1.4467
Last Price 1.3500
1st Support Level 1.2967
2nd Support Level 1.2433
3rd Support Level 1.1467

See More

52-Week High 15.6400
Fibonacci 61.8% 10.1471
Fibonacci 50% 8.4503
Fibonacci 38.2% 6.7535
Last Price 1.3500
52-Week Low 1.2606

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar